Company NameGlaxosmithkline Intellectual Property Holdings Limited
Company StatusActive
Company Number08283289
CategoryPrivate Limited Company
Incorporation Date6 November 2012(9 years, 6 months ago)

Business Activity

Section KFinancial and insurance activities
SIC 64209Activities of other holding companies n.e.c.

Directors

Director NameMr Adam Walker
Date of BirthNovember 1967 (Born 54 years ago)
NationalityBritish
StatusCurrent
Appointed28 March 2013(4 months, 3 weeks after company formation)
Appointment Duration9 years, 2 months
RoleAccountant
Country of ResidenceEngland
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMs Kate Sophie Priestman
Date of BirthNovember 1973 (Born 48 years ago)
NationalityBritish
StatusCurrent
Appointed09 December 2016(4 years, 1 month after company formation)
Appointment Duration5 years, 5 months
RoleStrategy Professional
Country of ResidenceUnited Kingdom
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMr Jerome Charles Maurice Andries
Date of BirthMay 1969 (Born 53 years ago)
NationalityFrench
StatusCurrent
Appointed01 October 2017(4 years, 10 months after company formation)
Appointment Duration4 years, 8 months
RoleCompany Director
Country of ResidenceEngland
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMr James Russell Wheatcroft
Date of BirthOctober 1967 (Born 54 years ago)
NationalityBritish
StatusCurrent
Appointed01 July 2019(6 years, 7 months after company formation)
Appointment Duration2 years, 11 months
RoleVp Controller R & D Director
Country of ResidenceEngland
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameEdinburgh Pharmaceutical Industries Limited (Corporation)
StatusCurrent
Appointed06 November 2012(same day as company formation)
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameEdinburgh Pharmaceutical Industries Limited (Corporation)
StatusCurrent
Appointed06 November 2012(same day as company formation)
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameGlaxo Group Limited (Corporation)
StatusCurrent
Appointed06 November 2012(same day as company formation)
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Secretary NameEdinburgh Pharmaceutical Industries Limited (Corporation)
StatusCurrent
Appointed06 November 2012(same day as company formation)
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Secretary NameEdinburgh Pharmaceutical Industries Limited (Corporation)
StatusCurrent
Appointed06 November 2012(same day as company formation)
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMr Paul Frederick Blackburn
Date of BirthOctober 1954 (Born 67 years ago)
NationalityBritish
StatusResigned
Appointed06 November 2012(same day as company formation)
RoleFinancial Controller
Country of ResidenceUnited Kingdom
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMr Simon Paul Dingemans
Date of BirthApril 1963 (Born 59 years ago)
NationalityBritish
StatusResigned
Appointed06 November 2012(same day as company formation)
RoleCompany Director
Country of ResidenceUnited Kingdom
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameMr Fraser Gemmell Macfarlane
Date of BirthDecember 1970 (Born 51 years ago)
NationalityBritish
StatusResigned
Appointed28 March 2013(4 months, 3 weeks after company formation)
Appointment Duration3 years, 7 months (resigned 01 November 2016)
RoleVp, Research & Development
Country of ResidenceEngland
Correspondence Address980 Great West Road
Brentford
Middlesex
TW8 9GS
Director NameLuigi Felice La Corte
Date of BirthDecember 1969 (Born 52 years ago)
NationalityItalian
StatusResigned
Appointed20 April 2015(2 years, 5 months after company formation)
Appointment Duration2 years, 5 months (resigned 30 September 2017)
RoleSvp Finance, Pharma, R&D
Country of ResidenceUnited Kingdom
Correspondence AddressGsk 980 Great West Road
Brentford
Middlesex
TW8 9GS

Contact

Websitegsk.com

Location

Registered Address980 Great West Road
Brentford
Middlesex
TW8 9GS
RegionLondon
ConstituencyBrentford and Isleworth
CountyGreater London
WardBrentford
Built Up AreaGreater London
Address MatchesOver 100 other UK companies use this postal address

Shareholders

101 at £1Glaxosmithkline Llc
50.25%
Ordinary A
100 at £1Glaxo Group LTD
49.75%
Ordinary B

Financials

Year2014
Net Worth£2,147,483,647
Current Liabilities£1,940,045,000

Accounts

Latest Accounts31 December 2020 (1 year, 4 months ago)
Next Accounts Due30 September 2022 (4 months from now)
Accounts CategoryFull
Accounts Year End31 December

Returns

Latest Return10 September 2021 (8 months, 3 weeks ago)
Next Return Due24 September 2022 (3 months, 3 weeks from now)

Filing History

28 September 2021Confirmation statement made on 10 September 2021 with no updates (3 pages)
27 September 2021Full accounts made up to 31 December 2020 (21 pages)
9 October 2020Full accounts made up to 31 December 2019 (20 pages)
24 September 2020Confirmation statement made on 10 September 2020 with no updates (3 pages)
24 September 2019Full accounts made up to 31 December 2018 (20 pages)
10 September 2019Confirmation statement made on 10 September 2019 with no updates (3 pages)
3 September 2019Appointment of Mr James Russell Wheatcroft as a director on 1 July 2019 (2 pages)
7 May 2019Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019 (1 page)
3 December 2018Confirmation statement made on 6 November 2018 with no updates (3 pages)
6 October 2018Full accounts made up to 31 December 2017 (17 pages)
5 March 2018Notification of Glaxosmithkline Finance Plc as a person with significant control on 6 April 2016 (2 pages)
5 March 2018Change of details for Glaxo Group Limited as a person with significant control on 6 April 2016 (2 pages)
30 January 2018Director's details changed for Mr Jerome Charles Maurice Andries on 14 November 2017 (4 pages)
17 November 2017Confirmation statement made on 6 November 2017 with updates (4 pages)
17 November 2017Appointment of Mr Jerome Charles Maurice Andries as a director on 1 October 2017 (2 pages)
17 November 2017Confirmation statement made on 6 November 2017 with updates (4 pages)
17 November 2017Appointment of Mr Jerome Charles Maurice Andries as a director on 1 October 2017 (2 pages)
16 November 2017Termination of appointment of Luigi Felice La Corte as a director on 30 September 2017 (1 page)
16 November 2017Termination of appointment of Luigi Felice La Corte as a director on 30 September 2017 (1 page)
28 September 2017Full accounts made up to 31 December 2016 (18 pages)
28 September 2017Full accounts made up to 31 December 2016 (18 pages)
7 January 2017Appointment of Kate Sophie Priestman as a director on 9 December 2016 (3 pages)
7 January 2017Appointment of Kate Sophie Priestman as a director on 9 December 2016 (3 pages)
21 December 2016Statement of capital following an allotment of shares on 16 December 2016
  • GBP 203
(3 pages)
21 December 2016Statement of capital following an allotment of shares on 16 December 2016
  • GBP 203
(3 pages)
18 November 2016Confirmation statement made on 6 November 2016 with updates (6 pages)
18 November 2016Confirmation statement made on 6 November 2016 with updates (6 pages)
2 November 2016Termination of appointment of Fraser Gemmell Macfarlane as a director on 1 November 2016 (1 page)
2 November 2016Termination of appointment of Fraser Gemmell Macfarlane as a director on 1 November 2016 (1 page)
28 September 2016Full accounts made up to 31 December 2015 (16 pages)
28 September 2016Full accounts made up to 31 December 2015 (16 pages)
8 February 2016Termination of appointment of Paul Frederick Blackburn as a director on 1 February 2016 (1 page)
8 February 2016Termination of appointment of Paul Frederick Blackburn as a director on 1 February 2016 (1 page)
14 December 2015Annual return made up to 6 November 2015 with a full list of shareholders
Statement of capital on 2015-12-14
  • GBP 202
(8 pages)
14 December 2015Annual return made up to 6 November 2015 with a full list of shareholders
Statement of capital on 2015-12-14
  • GBP 202
(8 pages)
24 September 2015Full accounts made up to 31 December 2014 (13 pages)
24 September 2015Full accounts made up to 31 December 2014 (13 pages)
15 May 2015Appointment of Luigi Felice La Corte as a director on 20 April 2015 (3 pages)
15 May 2015Appointment of Luigi Felice La Corte as a director on 20 April 2015 (3 pages)
14 January 2015Statement of capital following an allotment of shares on 17 December 2014
  • GBP 202
(3 pages)
14 January 2015Statement of capital following an allotment of shares on 17 December 2014
  • GBP 202
(3 pages)
8 December 2014Annual return made up to 6 November 2014 with a full list of shareholders
Statement of capital on 2014-12-08
  • GBP 201
(7 pages)
8 December 2014Annual return made up to 6 November 2014 with a full list of shareholders
Statement of capital on 2014-12-08
  • GBP 201
(7 pages)
8 December 2014Annual return made up to 6 November 2014 with a full list of shareholders
Statement of capital on 2014-12-08
  • GBP 201
(7 pages)
16 August 2014Full accounts made up to 31 December 2013 (11 pages)
16 August 2014Full accounts made up to 31 December 2013 (11 pages)
2 July 2014Previous accounting period extended from 30 November 2013 to 31 December 2013 (1 page)
2 July 2014Previous accounting period extended from 30 November 2013 to 31 December 2013 (1 page)
16 January 2014Statement of capital following an allotment of shares on 19 December 2013
  • GBP 201
(4 pages)
16 January 2014Statement of capital following an allotment of shares on 19 December 2013
  • GBP 201
(4 pages)
19 December 2013Annual return made up to 6 November 2013 with a full list of shareholders (7 pages)
19 December 2013Annual return made up to 6 November 2013 with a full list of shareholders (7 pages)
19 December 2013Annual return made up to 6 November 2013 with a full list of shareholders (7 pages)
17 May 2013Appointment of Dr Fraser Gemmell Macfarlane as a director (3 pages)
17 May 2013Appointment of Dr Fraser Gemmell Macfarlane as a director (3 pages)
1 May 2013Appointment of Adam Walker as a director (3 pages)
1 May 2013Appointment of Adam Walker as a director (3 pages)
31 January 2013Statement of capital following an allotment of shares on 31 December 2012
  • GBP 200
(4 pages)
31 January 2013Change of share class name or designation (2 pages)
31 January 2013Particulars of variation of rights attached to shares (2 pages)
31 January 2013Statement of capital following an allotment of shares on 31 December 2012
  • GBP 200
(4 pages)
31 January 2013Change of share class name or designation (2 pages)
31 January 2013Particulars of variation of rights attached to shares (2 pages)
11 January 2013Memorandum and Articles of Association (33 pages)
11 January 2013Resolutions
  • RES01 ‐ Resolution of Memorandum and/or Articles of Association
(3 pages)
11 January 2013Memorandum and Articles of Association (33 pages)
11 January 2013Resolutions
  • RES01 ‐ Resolution of Memorandum and/or Articles of Association
(3 pages)
6 November 2012Incorporation (51 pages)
6 November 2012Incorporation (51 pages)